Recorded live at Antibody Engineering & Therapeutics in San Diego, Episode 3 of Antibodies! brings together leading voices from across the antibody discovery and development community for a series of conversations on some of the field’s most important challenges and opportunities.
Hosted by Jonathan Davis, PhD, Founder of Creative Antibodies, this special conference edition features discussions on target discovery, tumor specificity, bispecific and trispecific antibodies, intracellular targets, antibody developability, Fc effector functions, nanobody discovery, and the growing role of artificial intelligence in antibody research.
From emerging antibody formats and next generation targeting strategies to AI enabled discovery and developability assessment, this episode offers a snapshot of the ideas shaping the future of antibody therapeutics.
